Datapoint: Elevance Unveils New Specialty Drug Approach
CarelonRx, the PBM arm of Elevance Health, Inc., has a new “comprehensive approach to specialty medication savings across pharmacy and medical benefits,” according to an April 22 press release. The new product will use “advanced analytics” to “identify members whose health is at the greatest risk,” which will prompt “a thorough review of a member’s clinical diagnoses, medications, whole-health integrated support, and a review of their site of care options.” At that point, identified members will receive “proactive pharmacist-led outreach to address any barriers to care, and to further coordinate integrated care with their whole health team, including medical and behavioral health professionals.” Elevance currently serves 11,934,672 pharmacy lives across all insurance channels, according to data from AIS Health’s parent company, MMIT.
SOURCE: MMIT Analytics, as of 4/29/24
